跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 85 条关于
“F508del”
全部
85
临床试验
71
药物
3
机构
0
资讯
11
去年
Elexacaftor–Tezacaftor–Ivacaftor Shows Promise for Cystic Fibrosis Patients Without F508del CFTR Variant
去年
NICE Recommends Vanzacaftor-Tezacaftor-Deutivacaftor for Cystic Fibrosis Treatment in England
去年
Real-World Data Confirms Trikafta's Long-Term Efficacy as Gold Standard in Cystic Fibrosis Treatment
2年前
TRIKAFTA Expanded by FDA to Treat Younger Cystic Fibrosis Patients and Additional Mutations
8年前
CHMP Backs Novel Therapies: Onpattro for hATTR and Symkevi for Cystic Fibrosis
去年
AbbVie and Galapagos Form $406 Million Alliance to Develop Novel Cystic Fibrosis Therapies
11天前
Aptar and Aceso Therapeutics Partner to Advance Inhaled Antisense Oligonucleotide Therapy for Cystic Fibrosis
10年前
FDA Approves Record 45 New Drugs in 2015, Led by Breakthrough Cancer Immunotherapy Opdivo
去年
Vertex's ALYFTREK Approved by FDA as Next-Generation Cystic Fibrosis Treatment
去年
Vertex Scientists Win Prestigious Lasker Award for Revolutionary Cystic Fibrosis Treatment
第 1 页,共 2 页
上一页
下一页